SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Q&A: Breast cancer facts that could save lives

2.

Chemicals in Sewage Sludge Fertilizer Pose Cancer Risk, EPA Says

3.

Low Income, Education Tied to Depression in Older Adults

4.

Remote monitoring can improve recovery from cancer surgery

5.

The First Gene Therapy Provides a Durable Response for Non-Muscle-Invasive Bladder Cancer.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot